文献速递消化内镜胰腺与胆道疾病

ERCP术后胆囊炎:来自前瞻性多中心胆道内镜登记研究的发生率、特征和结局

Post-ERCP cholecystitis: Incidence, characteristics, and outcomes from a prospective multicenter biliary endoscopy registry.
PubMed 文献 · Gastrointest Endosc · 2023-12-11

基于7个中心2018至2023年前瞻性登记、按协议随访30天的4428例有胆囊患者行ERCP的数据,ERCP术后胆囊炎发生率为0.38%(95%CI 0.20-0.57),覆盖金属支架置入的ERCP中为1.50%(95%CI 0.40-2.60);症状中位出现于术后5天,处理包括胆囊切除术、经皮胆囊造瘘和內镜下支架取出/更换。

要点

  • ERCP术后胆囊炎总体发生率为0.38%(95%CI 0.20-0.57)。
  • 覆盖金属支架置入的ERCP中发生率为1.50%(95%CI 0.40-2.60)。
  • 症状中位出现时间为ERCP术后5天(四分位距5)。

核心结论

  • ERCP术后胆囊炎发生率估计值可为操作风险的讨论提供参考。

研究设计与样本

  • 前瞻性多中心胆道内镜登记研究,纳入7个中心2018至2023年有胆囊并接受ERCP的患者4428例,按协议进行30天随访。

主要发现

  • 4428例有胆囊患者中识别出17例ERCP术后胆囊炎,发生率为0.38%(95%CI 0.20-0.57)。
  • 覆盖金属支架置入的467例ERCP中7例发生胆囊炎,发生率为1.50%(95%CI 0.40-2.60)。
  • 患者症状出现的中位时间为ERCP术后5天(四分位距5)。

关键数值与推荐

  • ERCP术后胆囊炎根据基于德尔菲法的标准和因果归因系统定义。

临床怎么用

  • 处理策略包括胆囊切除术、经皮胆囊造瘘和內镜下支架取出/更换。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The incidence, risk factors, and outcomes of post-ERCP cholecystitis are poorly described. We aimed to describe cases of post-ERCP cholecystitis from a prospective multicenter registry with protocolized 30-day follow-up. METHODS: Patient- and procedure-related data from 7 centers were obtained. The primary outcome was post-ERCP cholecystitis, defined according to a Delphi-based criteria and causal attribution system. Risk factors and outcomes were described for all cases. RESULTS: Seventeen cases of post-ERCP cholecystitis were identified among 4428 patients with gallbladders undergoing ERCP between 2018 and 2023 (incidence, 0.38%; 95% confidence interval, 0.20-0.57). In ERCPs with covered metal stenting, 7 of 467 resulted in cholecystitis (incidence, 1.50%; 95% confidence interval, 0.40-2.60). Patients had symptoms at a median of 5 days (interquartile range, 5) after ERCP. Management strategies included cholecystectomy, percutaneous cholecystostomy, and endoscopic stent removal/exchange. CONCLUSIONS: Estimates of post-ERCP cholecystitis incidence can inform discussions around procedural risk.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Khan R, Osman H, Lee S, et al. Post-ERCP cholecystitis: Incidence, characteristics, and outcomes from a prospective multicenter biliary endoscopy registry. Gastrointest Endosc. 2023. PMID: 38092126. doi:10.1016/j.gie.2023.12.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。